PMDA — authorised 22 January 2021
- Marketing authorisation holder: NIHON PHARMACEUTICAL CO., LTD.
- Status: approved
PMDA authorised Suprep Bowel Prep Kit on 22 January 2021
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 22 January 2021.
NIHON PHARMACEUTICAL CO., LTD. holds the Japanese marketing authorisation.